Specifically, the GLP-1/Estrogen combination has shown superior efficacy compared to metformin and other multi-agonists in managing the metabolic complications of PCOS, while also enhancing ovarian cyclicity in an anovulatory PCOS model (74). The gene discussed is GLP1R; the disease is polycystic ovary syndrome.